United
States
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): August 21, 2009 (August 19, 2009)
ePlus inc.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
1-34167
|
|
54-1817218
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission File Number)
|
|
(I.R.S.
Employer Identification
No.)
|
13595
Dulles Technology Drive Herndon, VA 20171-3413
(Address,
including zip code, of principal executive offices)
Registrant’s
telephone number, including area code: (703) 984-8400
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2 below):
[]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
[]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item
7.01 Regulation FD Disclosure
As
previously disclosed, ePlus
inc. (the “Company”) filed a complaint in May 2009 in the United States District
Court for the Eastern District of Virginia against four defendants, alleging
that they used or sold products, methods, processes, services and/or systems
that infringe on certain of its patents. In July 2009, the Company
entered into a settlement agreement with one defendant. On August 19,
2009, the Company entered into a Settlement and License Agreement (“the
Agreement”) with a second defendant. Pursuant to the Agreement, the
Company has received $2.4 million for the license of certain of its
patents.
Pursuant to the requirements of the Securities and Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.